EDNA OBEHI IDEHEN

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CONCORD, NC NPI 1780170571

General Payments — all program years on this page

$1,290.31

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 48
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $646.76 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $646.7619

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $11.351
2023 $632.2028
2024 $646.7619

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1082666865 Neos Therapeutics, LP $20.10 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100112280 Corium, LLC $15.21 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100221685 Corium, LLC $24.21 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100221945 Corium, LLC $22.45 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100222159 Corium, LLC $34.23 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137767423 Takeda Pharmaceuticals U.S.A., Inc. $25.00 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137767425 Takeda Pharmaceuticals U.S.A., Inc. $14.73 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143510041 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.22 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143510045 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.46 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143510050 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.78 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146288434 IRONSHORE PHARMACEUTICALS INC. $14.94 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146766212 IDORSIA PHARMACEUTICALS US INC $15.17 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147217786 Tris Pharma Inc $19.12 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147217788 Tris Pharma Inc $22.49 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147217790 Tris Pharma Inc $23.86 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147217792 Tris Pharma Inc $23.96 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147867872 Supernus Pharmaceuticals, Inc. $272.79 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150953663 Neurocrine Biosciences, Inc. $25.39 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150976499 Neurocrine Biosciences, Inc. $20.65 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.